Search in:

mAbs Volume 14, 2022 - Issue 1

Submit an article Journal homepage

Open access

4,962

Views

CrossRef citations to date

Altmetric

Report

International nonproprietary names for monoclonal antibodies: an evolving nomenclature system

Sofia S. Guimaraes Kocha INN Unit, WHO, Geneva, SwitzerlandCorrespondence[email protected]
View further author information

Robin Thorpeb Welwyn, UKView further author information

Nana Kawasakic Yokohama City University, Yokohama, Japan

https://orcid.org/0000-0002-5447-1890 View further author information

Marie-Paule Lefrancd Institut Universitaire de France, Université de Montpellier, Laboratoire d’ImmunoGénétique Moléculaire LIGM, Institut de Génétique Humaine IGH, Montpellier, FranceView further author information

Sarel Malane School of Pharmacy, University of the Western Cape, Bellville, South Africa

https://orcid.org/0000-0002-1640-6457 View further author information

Andrew C.R. Martinf Institute of Structural & Molecular Biology, Division of Biosciences, University College London, London, UKView further author information

Gilles Mignotg Nice, FranceView further author information

Andreas Plückthunh Department of Biochemistry, University of Zurich, Zurich, Switzerland

https://orcid.org/0000-0003-4191-5306 View further author information

Menico Rizzii Department of Pharmaceutical Sciences, University of Piemonte Orientale, Novara, ItalyView further author information

Stephanie Shubatj United States Adopted Names (USAN) Program, Chicago, Illinois, USAView further author information

Karin Weisserk Paul-Ehrlich-Institut, Langen, GermanyView further author information

Raffaella Baloccoa INN Unit, WHO, Geneva, SwitzerlandView further author information

show all

Article: 2075078 | Received 22 Feb 2022, Accepted 04 May 2022, Published online: 18 May 2022

Cite this article
https://doi.org/10.1080/19420862.2022.2075078
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

World Intellectual Property Organization. About the nice classification. [accessed 2022 April 27]. https://www.wipo.int/classifications/nice/en/preface.html
Google Scholar
World Intellectual Property Organization. Class 5 of nice classification. [accessed 2022 April 27]. https://www.wipo.int/classifications/nice/nclpub/en/fr/?class_number=5
Google Scholar
The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances. Geneva (Switzerland): World Health Organization; 2018. [accessed 2022 April 27]. https://cdn.who.int/media/docs/default-source/international-nonproprietary-names-(inn)/stembook-2018.pdf
Google Scholar
International Nonproprietary Names (INN) for biological and biotechnological substances (a review). Geneva (Switzerland): World Health Organization; 2019. [accessed 2022 April 27]. https://cdn.who.int/media/docs/default-source/international-nonproprietary-names-(inn)/bioreview2019.pdf
Google Scholar
Robertson JS, Loizides U, Adisa A, López de la Rica Manjavacas A, Rodilla V, Strnadova C, Weisser K, Balocco R. International Nonproprietary Names (INN) for novel vaccine substances: a matter of safety. Vaccine. 2022;40(1):21–9. doi:10.1016/j.vaccine.2021.11.054. PMID: 34844820
PubMed Web of Science ®Google Scholar
Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256(5517):495–97. doi:10.1038/256495a0.
PubMed Web of Science ®Google Scholar
Ecker DM, Jones SD, Levine HL. The therapeutic monoclonal antibody market. MAbs. 2015;7(1):9–14. doi:10.4161/19420862.2015.989042. PMID: 25529996
PubMed Web of Science ®Google Scholar
The Antibody Society. Therapeutic monoclonal antibodies approved or in review in the EU or US. [accessed 2022 April 27]. https://www.antibodysociety.org/resources/approved-antibodies/
Google Scholar
International nonproprietary names: revised procedure. Geneva (Switzerland): World Health Organization; 2004. [accessed 2022 April 27]. https://apps.who.int/gb/archive/pdf_files/EB115/B115_11-en.pdf
Google Scholar
WHO Drug Information. Vol. 2 (2), List 59 of proposed International Nonproprietary Names (INN) for pharmaceutical substances. Geneva (Switzerland): World Health Organization; 1988. [accessed 2022 April 27]. https://cdn.who.int/media/docs/default-source/international-nonproprietary-names-(inn)/pl59.pdf
Google Scholar
Guidance on the use of international nonproprietary names (INNs) for pharmaceutical substances. Geneva (Switzerland): World Health Organization; 2017. [accessed 2022 April 27]. https://cdn.who.int/media/docs/default-source/international-nonproprietary-names-(inn)/who-pharm-s-nom-1570.pdf
Google Scholar
WHO Drug Information. Vol. 5 (4), List 66 of proposed international nonproprietary names (INN) for pharmaceutical substances. Geneva (Switzerland): World Health Organization; 1991. [accessed 2022 April 27]. https://cdn.who.int/media/docs/default-source/international-nonproprietary-names-(inn)/pl66.pdf
Google Scholar
WHO Drug Information. Vol. 23 (4), List 102 of proposed international nonproprietary names (INN) for pharmaceutical substances. Geneva (Switzerland): World Health Organization; 2009. [accessed 2022 April 27] https://cdn.who.int/media/docs/default-source/international-nonproprietary-names-(inn)/pl102.pdf
Google Scholar
WHO Drug Information. Vol. 31 (4). List 118 of proposed International Nonproprietary Names (INN) for pharmaceutical substances. Geneva (Switzerland): World Health Organization; 2017. [accessed 2022 April 27]. https://cdn.who.int/media/docs/default-source/international-nonproprietary-names-(inn)/pl118.pdf
Google Scholar
Jones TD, Carter PJ, Plückthun A, Vásquez M, Holgate RGE, Hötzel I, Popplewell AG, Parren PWHI, Enzelberger M, Rademaker HJ, et al. The INNs and outs of antibody nonproprietary names. MAbs. 2016;8(1):1–9. PMID: 26716992. doi:10.1080/19420862.2015.1114320.
PubMed Web of Science ®Google Scholar
Baker MP, Reynolds HM, Lumicisi B, Bryson CJ. Immunogenicity of protein therapeutics: the key causes, consequences and challenges. Self Nonself. 2010;1(4):314–22. doi:10.4161/self.1.4.13904. PMID: 21487506
PubMedGoogle Scholar
Schellekens H. The immunogenicity of therapeutic proteins. Discov Med. 2010;9(49):560–64. PMID: 20587346
PubMed Web of Science ®Google Scholar
New INN monoclonal antibody (mAb) nomenclature scheme. Geneva (Switzerland): World Health Organization; [accessed 2022 May 11]. https://cdn.who.int/media/docs/default-source/international-nonproprietary-names-(inn)/new_mab_nomenclature-_2021rev.pdf
Google Scholar
Robertson JS, Chui WK, Genazzani AA, Malan SF, López de la Rica Manjavacas A, Mignot G, Thorpe R, Balocco R, Rizzi M. The INN global nomenclature of biological medicines: a continuous challenge. Biologicals. 2019;60:15–23. PMID: 31130314. doi:10.1016/j.biologicals.2019.05.006.
PubMed Web of Science ®Google Scholar
Loizides U, Dominici M, Manderson T, Rizzi M, Robertson JS, de Sousa Guimarães Koch S, Timón M, Balocco R. The harmonization of World Health Organization International Nonproprietary Names definitions for cell and cell-based gene therapy substances: when a name is not enough. Cytotherapy. 2021;23(5):357–66. doi:10.1016/j.jcyt.2021.02.114. PMID: 33820700
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

International nonproprietary names for monoclonal antibodies: an evolving nomenclature system

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

International nonproprietary names for monoclonal antibodies: an evolving nomenclature system

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date